In another blow to the Trump Administration, there is another high-level ouster of a healthcare leader.
On January 31, Brenda Fitzgerald resigned as head of the Centers for Disease Control and Prevention (CDC), after Politico reported on her tobacco investments and the conflict those caused with her federal role.
In a statement, a Health and Human Services Secretary spokesperson noted Fitzgerald’s “complex financial interests” that repeatedly caused her to recuse herself from CDC business.
“Due to the nature of these financial interests, Dr. Fitzgerald could not divest from them in a definitive time period,” the statement read. The statement came a few hours after Politico published a story indicating that Fitzgerald purchased shares in tobacco companies after assuming her post at the CDC.
Politico also published stories last fall regarding former HHS Secretary Tom Price’s use of taxpayer-funded airplanes for personal use that led to his resignation from the department, paving the way for Alex Azar.
An HHS spokesperson told Medical Economics that Anne Schuchat, MD, formerly principal deputy director, is now the acting director of the CDC. With a background in internal medicine, here are five other facts physicians should know about the new head of the agency.